Investors
- Stock Information
- News Releases
- Corporate Governance
- SEC Filings
- Annual Reports
- Financial Reports
- Event Calendar
- Presentations
- Non-GAAP Measures
- FAQ
- Information Request
- Analyst Coverage
For Pharmaceuticals
spin-off information,
click here.
News Release
 View printer-friendly version |
| << Back |
| Covidien Ltd. to Report Second-Quarter Results on May 6, 2008 |
HAMILTON, Bermuda--(BUSINESS WIRE)--April 9, 2008--Covidien Ltd. (NYSE: COV, BSX: COV) will report second-quarter results before trading begins on May 6, 2008. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
-- At Covidien's website: http://investor.covidien.com
-- By telephone: For both "listen-only" participants and those
participants who wish to take part in the question-and-answer
portion of the call, the telephone dial-in number in the U.S.
is 800-322-5044. For participants outside the U.S., the
dial-in number is 617-614-4927. The access code for all
callers is 80983121.
-- Through an audio replay: A replay of the conference call will
be available beginning at 10:30 a.m. on May 6, 2008, and
ending at 11:59 p.m. on May 13, 2008. The dial-in number for
U.S. participants is 888-286-8010. For participants outside
the U.S., the replay dial-in number is 617-801-6888. The
replay access code for all callers is 33653329.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business.
CONTACT: Covidien Ltd. |